Safety of Remdesivir in Patients With Acute Kidney Injury or CKD

Valeri, 2020, Presentation and outcomes of patients with ESKD and COVID-19, J Am Soc Nephrol, 31, 1409, 10.1681/ASN.2020040470

Beigel, 2020, Remdesivir for the treatment of Covid-19 – final report, N Engl J Med, 383, 1813, 10.1056/NEJMoa2007764

RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19 – preliminary report [e-pub ahead of print]. N Engl J Med. https://doi.org/10.1056/NEJMoa2021436. Accessed November 1, 2020.

Adamsick, 2020, Remdesivir in patients with acute or chronic kidney disease and COVID-19, J Am Soc Nephrol, 31, 1384, 10.1681/ASN.2020050589

Luke, 2020, Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD), J Pharm Sci, 99, 3291, 10.1002/jps.22109

Luke, 2012, Pharmacokinetics of sulfobutylether-β-cyclodextrin (SBECD) in subjects on hemodialysis, Nephrol Dial Transplant, 27, 1207, 10.1093/ndt/gfr472